The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online 14 March 2005 doi:10.1084/jem.20042239
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 201, Number 6, 993-1005
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1162K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gatto, D.
Right arrow Articles by Bachmann, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gatto, D.
Right arrow Articles by Bachmann, M. F.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

 Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1

Dominique Gatto1, Thomas Pfister1, Andrea Jegerlehner1, Stephen W. Martin1, Manfred Kopf2, and Martin F. Bachmann1

1 Cytos Biotechnology, Swiss Federal Institute of Technology, Zurich-Schlieren 8952, Switzerland
2 Molecular Biomedicine, Swiss Federal Institute of Technology, Zurich-Schlieren 8952, Switzerland

CORRESPONDENCE Martin F. Bachmann: martin.bachmann{at}cytos.com

Humoral immune responses are thought to be enhanced by complement-mediated recruitment of the CD21–CD19–CD81 coreceptor complex into the B cell antigen receptor (BCR) complex, which lowers the threshold of B cell activation and increases the survival and proliferative capacity of responding B cells. To investigate the role of the CD21–CD35 complement receptors in the generation of B cell memory, we analyzed the response against viral particles derived from the bacteriophage Qß in mice deficient in CD21–CD35 (Cr2–/–). Despite highly efficient induction of early antibody responses and germinal center (GC) reactions to immunization with Qß, Cr2–/– mice exhibited impaired antibody persistence paralleled by a strongly reduced development of bone marrow plasma cells. Surprisingly, antigen-specific memory B cells were essentially normal in these mice. In the absence of CD21-mediated costimulation, Qß-specific post-GC B cells failed to induce the transcriptional regulators Blimp-1 and XBP-1 driving plasma cell differentiation, and the antiapoptotic protein Bcl-2, which resulted in failure to generate the precursor population of long-lived plasma cells residing in the bone marrow. These results suggest that complement receptors maintain antibody responses by delivery of differentiation and survival signals to precursors of bone marrow plasma cells.

Abbreviations used: ASC, antibody-secreting cell; BCR, B cell Ag receptor; FDC, follicular dendritic cell; GC, germinal center; NP, (4-hydroxy-3-nitrophenyl)acetyl; PNA, peanut agglutinin.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS